BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Higashi T, Hayashi H, Ishimoto T, Takeyama H, Kaida T, Arima K, Taki K, Sakamoto K, Kuroki H, Okabe H, Nitta H, Hashimoto D, Chikamoto A, Beppu T, Baba H. miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells. Br J Cancer 2015;113:252-8. [PMID: 26125451 DOI: 10.1038/bjc.2015.170] [Cited by in Crossref: 57] [Cited by in F6Publishing: 66] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Zhao R, Jiao X, Wu L, Wei Y, Shi F, Zhong J, Xiong L. Small Extracellular Vesicles: Functions and Potential Clinical Applications as Cancer Biomarkers. Life (Basel) 2021;11:1044. [PMID: 34685415 DOI: 10.3390/life11101044] [Reference Citation Analysis]
2 Zhou Y, Yang L, Bo C, Zhang X, Zhang J, Li Y. MicroRNA-9-3p Aggravates Cerebral Ischemia/Reperfusion Injury by Targeting Fibroblast Growth Factor 19 (FGF19) to Inactivate GSK-3β/Nrf2/ARE Signaling. Neuropsychiatr Dis Treat 2021;17:1989-2002. [PMID: 34177264 DOI: 10.2147/NDT.S290237] [Reference Citation Analysis]
3 Guan Q, Yuan B, Zhang X, Yan T, Li J, Xu W. Long non-coding RNA DUXAP8 promotes tumorigenesis by regulating IGF1R via miR-9-3p in hepatocellular carcinoma. Exp Ther Med 2021;22:755. [PMID: 34035852 DOI: 10.3892/etm.2021.10187] [Reference Citation Analysis]
4 Yang M, Tang X, Wang Z, Wu X, Tang D, Wang D. miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ. Biosci Rep 2019;39:BSR20190193. [PMID: 31782506 DOI: 10.1042/BSR20190193] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
5 Tran DDH, Kessler C, Niehus SE, Mahnkopf M, Koch A, Tamura T. Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs. Oncogene 2018;37:75-85. [DOI: 10.1038/onc.2017.312] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
6 Wu N, Zhu Q, Chen B, Gao J, Xu Z, Li D. High-throughput sequencing of pituitary and hypothalamic microRNA transcriptome associated with high rate of egg production. BMC Genomics 2017;18:255. [PMID: 28335741 DOI: 10.1186/s12864-017-3644-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
7 Meng Q, Xiang L, Fu J, Chu X, Wang C, Yan B. Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer. Oncotarget 2017;8:37321-31. [PMID: 28418879 DOI: 10.18632/oncotarget.16310] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
8 Zhu B, Finch-Edmondson M, Leong KW, Zhang X, V M, Lin QXX, Lee Y, Ng WT, Guo H, Wan Y, Sudol M, DasGupta R. LncRNA SFTA1P mediates positive feedback regulation of the Hippo-YAP/TAZ signaling pathway in non-small cell lung cancer. Cell Death Discov 2021;7:369. [PMID: 34845189 DOI: 10.1038/s41420-021-00761-0] [Reference Citation Analysis]
9 Zheng Z, Wen Y, Nie K, Tang S, Chen X, Lan S, Pan J, Jiang K, Jiang X, Liu P, Yan Y, Liu F, Liu Y, Li P. Construction of a 13-microRNA-based signature and prognostic nomogram for predicting overall survival in patients with hepatocellular carcinoma. Hepatol Res 2020;50:1151-63. [PMID: 32567216 DOI: 10.1111/hepr.13538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Barbano R, Pasculli B, Rendina M, Fontana A, Fusilli C, Copetti M, Castellana S, Valori VM, Morritti M, Graziano P, Luigi C, Coco M, Picardo F, Mazza T, Evron E, Murgo R, Maiello E, Esteller M, Fazio VM, Parrella P. Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients. Sci Rep 2017;7:45283. [PMID: 28345661 DOI: 10.1038/srep45283] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
11 Kovar H, Bierbaumer L, Radic-Sarikas B. The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis. Cells 2020;9:E972. [PMID: 32326412 DOI: 10.3390/cells9040972] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
12 Zhou X, Lei QY. Regulation of TAZ in cancer. Protein Cell 2016;7:548-61. [PMID: 27412635 DOI: 10.1007/s13238-016-0288-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
13 Wang S, Wu W, Claret FX. Mutual regulation of microRNAs and DNA methylation in human cancers. Epigenetics. 2017;12:187-197. [PMID: 28059592 DOI: 10.1080/15592294.2016.1273308] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 13.2] [Reference Citation Analysis]
14 Zhou W, Weng J, Wu K, Xu X, Wang H, Zhang J, Zhao C, Yang J, Zhang Y, Shen W. Silencing of TAZ inhibits the motility of hepatocellular carcinoma cells through autophagy induction. Cancer Manag Res 2019;11:8743-53. [PMID: 31576176 DOI: 10.2147/CMAR.S215466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Zhang K, Qi HX, Hu ZM, Chang YN, Shi ZM, Han XH, Han YW, Zhang RX, Zhang Z, Chen T, Hong W. YAP and TAZ Take Center Stage in Cancer. Biochemistry 2015;54:6555-66. [PMID: 26465056 DOI: 10.1021/acs.biochem.5b01014] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 7.9] [Reference Citation Analysis]
16 Wang H, Ma Y, Lin Y, Liu J, Chen R, Xu B, Liang Y. An Isoxazole Derivative SHU00238 Suppresses Colorectal Cancer Growth through miRNAs Regulation. Molecules 2019;24:E2335. [PMID: 31242597 DOI: 10.3390/molecules24122335] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Zhou X, Zhu HQ, Ma CQ, Li HG, Liu FF, Chang H, Lu J. MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression. Biomed Pharmacother. 2016;79:315-320. [PMID: 27044843 DOI: 10.1016/j.biopha.2016.02.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
18 Xia D, Li X, Niu Q, Liu X, Xu W, Ma C, Gu H, Liu Z, Shi L, Tian X, Chen X, Zhang Y. MicroRNA-185 suppresses pancreatic cell proliferation by targeting transcriptional coactivator with PDZ-binding motif in pancreatic cancer. Exp Ther Med 2018;15:657-66. [PMID: 29399068 DOI: 10.3892/etm.2017.5447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
19 Shao JL, Li H, Zhang XR, Zhang X, Li ZZ, Jiao GL, Sun GD. Identification of Serum Exosomal MicroRNA Expression Profiling in Menopausal Females with Osteoporosis by High-throughput Sequencing. Curr Med Sci 2020;40:1161-9. [PMID: 33428145 DOI: 10.1007/s11596-020-2306-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Xue W, Li L, Tian X, Fan Z, Yue Y, Zhang C, Ding X, Song X, Ma B, Zhai Y, Lu J, Kan Q, Zhao J. Integrated analysis profiles of long non-coding RNAs reveal potential biomarkers of drug resistance in lung cancer. Oncotarget 2017;8:62868-79. [PMID: 28968955 DOI: 10.18632/oncotarget.16444] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
21 Liu H, Du S, Lei T, Wang H, He X, Tong R, Wang Y. Multifaceted regulation and functions of YAP/TAZ in tumors (Review). Oncol Rep 2018;40:16-28. [PMID: 29749524 DOI: 10.3892/or.2018.6423] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
22 Bao Y, Zhang Y, Lu Y, Guo H, Dong Z, Chen Q, Zhang X, Shen W, Chen W, Wang X. Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition. Int J Biol Sci 2020;16:827-37. [PMID: 32071552 DOI: 10.7150/ijbs.32460] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
23 Jin L, Yi J, Gao Y, Han S, He Z, Chen L, Song H. MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma. Acta Biochim Biophys Sin 2016;48:810-9. [DOI: 10.1093/abbs/gmw073] [Reference Citation Analysis]
24 Zhou W, Zhang L, Chen P, Li S, Cheng Y. Thymine DNA glycosylase-regulated TAZ promotes radioresistance by targeting nonhomologous end joining and tumor progression in esophageal cancer. Cancer Sci 2020;111:3613-25. [PMID: 32808385 DOI: 10.1111/cas.14622] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhu B, V M, Finch-Edmondson M, Lee Y, Wan Y, Sudol M, DasGupta R. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:756. [PMID: 33670427 DOI: 10.3390/cancers13040756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Shi X, Zhu H, Liu T, Shen X, Zhu J. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action. Cancer Letters 2017;400:175-82. [DOI: 10.1016/j.canlet.2017.04.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
27 Yang L, Mu Y, Cui H, Liang Y, Su X. MiR-9-3p augments apoptosis induced by H2O2 through down regulation of Herpud1 in glioma. PLoS One 2017;12:e0174839. [PMID: 28430789 DOI: 10.1371/journal.pone.0174839] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
28 Bao H, Li X, Li H, Xing H, Xu B, Zhang X, Liu Z. MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX. J Biosci 2017;42:103-11. [PMID: 28229969 DOI: 10.1007/s12038-016-9662-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
29 Wang C, Zou J, Ma X, Wang E, Peng G. Mechanisms and implications of ADAR-mediated RNA editing in cancer. Cancer Lett 2017;411:27-34. [PMID: 28974449 DOI: 10.1016/j.canlet.2017.09.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
30 Li N, Xie C, Lu N. Crosstalk between Hippo signalling and miRNAs in tumour progression. FEBS J 2017;284:1045-55. [PMID: 27973704 DOI: 10.1111/febs.13985] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
31 Tinay I, Tan M, Gui B, Werner L, Kibel AS, Jia L. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer. Prostate 2018;78:927-37. [PMID: 29748958 DOI: 10.1002/pros.23650] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
32 Wang YW, Chen X, Ma R, Gao P. Understanding the CREB1-miRNA feedback loop in human malignancies. Tumour Biol 2016;37:8487-502. [PMID: 27059735 DOI: 10.1007/s13277-016-5050-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
33 Nguyen-Lefebvre AT, Selzner N, Wrana JL, Bhat M. The hippo pathway: A master regulator of liver metabolism, regeneration, and disease. FASEB J 2021;35:e21570. [PMID: 33831275 DOI: 10.1096/fj.202002284RR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Zu Y, Zhu Z, Lin M, Xu D, Liang Y, Wang Y, Qiao Z, Cao T, Yang D, Gao L, Jin P, Zhang P, Fu J, Zheng J. MiR-9 Promotes Apoptosis Via Suppressing SMC1A Expression in GBM Cell Lines. Curr Chem Genom Transl Med 2017;11:31-40. [PMID: 28868238 DOI: 10.2174/2213988501711010031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
35 El Ouarrat D, Isaac R, Lee YS, Oh DY, Wollam J, Lackey D, Riopel M, Bandyopadhyay G, Seo JB, Sampath-Kumar R, Olefsky JM. TAZ Is a Negative Regulator of PPARγ Activity in Adipocytes and TAZ Deletion Improves Insulin Sensitivity and Glucose Tolerance. Cell Metab 2020;31:162-173.e5. [PMID: 31708444 DOI: 10.1016/j.cmet.2019.10.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
36 Fu Q, Yang F, Xiang T, Huai G, Yang X, Wei L, Yang H, Deng S. A novel microRNA signature predicts survival in liver hepatocellular carcinoma after hepatectomy. Sci Rep 2018;8:7933. [PMID: 29785036 DOI: 10.1038/s41598-018-26374-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
37 Samji P, Rajendran MK, Warrier VP, Ganesh A, Devarajan K. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective. Cell Signal 2021;78:109858. [PMID: 33253912 DOI: 10.1016/j.cellsig.2020.109858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
38 Paziewska A, Mikula M, Dabrowska M, Kulecka M, Goryca K, Antoniewicz A, Dobruch J, Borowka A, Rutkowski P, Ostrowski J. Candidate diagnostic miRNAs that can detect cancer in prostate biopsy. Prostate 2018;78:178-85. [PMID: 29226351 DOI: 10.1002/pros.23427] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
39 Wu J, Li DD, Li JY, Yin YC, Li PC, Qiu L, Chen LM. Identification of microRNA-mRNA networks involved in cisplatin-induced renal tubular epithelial cells injury. Eur J Pharmacol 2019;851:1-12. [PMID: 30768982 DOI: 10.1016/j.ejphar.2019.02.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Han Y, Liu Y, Fu X, Zhang Q, Huang H, Zhang C, Li W, Zhang J. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1. J Physiol Biochem 2018;74:491-501. [PMID: 30006781 DOI: 10.1007/s13105-018-0642-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
41 Wang Y, Dong L, Wan F, Chen F, Liu D, Chen D, Long J. MiR-9-3p regulates the biological functions and drug resistance of gemcitabine-treated breast cancer cells and affects tumor growth through targeting MTDH. Cell Death Dis 2021;12:861. [PMID: 34552061 DOI: 10.1038/s41419-021-04145-1] [Reference Citation Analysis]
42 Lin CW, Lin PY, Yang PC. Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition. Stem Cells Int 2016;2016:2732705. [PMID: 26989421 DOI: 10.1155/2016/2732705] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
43 Wang X, Zhou Z, Zhang T, Wang M, Xu R, Qin S, Zhang S. Overexpression of miR-664 is associated with poor overall survival and accelerates cell proliferation, migration and invasion in hepatocellular carcinoma. Onco Targets Ther 2019;12:2373-81. [PMID: 30992673 DOI: 10.2147/OTT.S188658] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
44 Higashi T, Hayashi H, Kitano Y, Yamamura K, Kaida T, Arima K, Taki K, Nakagawa S, Okabe H, Nitta H. Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma. Med Oncol. 2016;33:123. [PMID: 27734263 DOI: 10.1007/s12032-016-0845-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
45 Xu D, Chen X, He Q, Luo C. MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1. Onco Targets Ther 2016;9:7047-57. [PMID: 27895497 DOI: 10.2147/OTT.S107235] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
46 Astamal RV, Maghoul A, Taefehshokr S, Bagheri T, Mikaeili E, Derakhshani A, Delashoub M, Taefehshokr N, Isazadeh A, Hajazimian S, Tran A, Baradaran B. Regulatory role of microRNAs in cancer through Hippo signaling pathway. Pathol Res Pract 2020;216:153241. [PMID: 33065484 DOI: 10.1016/j.prp.2020.153241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
47 Furth N, Aylon Y. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway. Cell Death Differ 2017;24:1488-501. [PMID: 28644436 DOI: 10.1038/cdd.2017.99] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 16.0] [Reference Citation Analysis]
48 Yang S, Cai H, Hu B, Tu J. LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values. Biosci Rep 2019;39:BSR20190615. [PMID: 31164410 DOI: 10.1042/BSR20190615] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Bahrami A, Jafari A, Ferns GA. The dual role of microRNA-9 in gastrointestinal cancers: oncomiR or tumor suppressor? Biomed Pharmacother 2021;145:112394. [PMID: 34781141 DOI: 10.1016/j.biopha.2021.112394] [Reference Citation Analysis]
50 Shang A, Lu WY, Yang M, Zhou C, Zhang H, Cai ZX, Wang WW, Wang WX, Wu GQ. miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway. Artif Cells Nanomed Biotechnol 2018;46:1754-62. [PMID: 29073835 DOI: 10.1080/21691401.2017.1391825] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
51 Zhan T, Huang X, Tian X, Chen X, Ding Y, Luo H, Zhang Y. Downregulation of MicroRNA-455-3p Links to Proliferation and Drug Resistance of Pancreatic Cancer Cells via Targeting TAZ. Mol Ther Nucleic Acids 2018;10:215-26. [PMID: 29499934 DOI: 10.1016/j.omtn.2017.12.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
52 Nasr MA, Salah RA, Abd Elkodous M, Elshenawy SE, El-Badri N. Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells. Front Cell Dev Biol 2019;7:229. [PMID: 31681762 DOI: 10.3389/fcell.2019.00229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
53 Wu F, Jiang X, Wang Q, Lu Q, He F, Li J, Li X, Jin M, Xu J. The impact of miR-9 in osteosarcoma: A study based on meta-analysis, TCGA data, and bioinformatics analysis. Medicine (Baltimore) 2020;99:e21902. [PMID: 32871922 DOI: 10.1097/MD.0000000000021902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Sadri Nahand J, Bokharaei-Salim F, Salmaninejad A, Nesaei A, Mohajeri F, Moshtzan A, Tabibzadeh A, Karimzadeh M, Moghoofei M, Marjani A, Yaghoubi S, Keyvani H. microRNAs: Key players in virus-associated hepatocellular carcinoma. J Cell Physiol 2019;234:12188-225. [PMID: 30536673 DOI: 10.1002/jcp.27956] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
55 Patel SH, Camargo FD, Yimlamai D. Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis. Gastroenterology 2017;152:533-45. [PMID: 28003097 DOI: 10.1053/j.gastro.2016.10.047] [Cited by in Crossref: 141] [Cited by in F6Publishing: 141] [Article Influence: 23.5] [Reference Citation Analysis]
56 Jin L, Yi J, Gao Y, Han S, He Z, Chen L, Song H. MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma. Acta Biochim Biophys Sin (Shanghai). 2016;48:810-819. [PMID: 27563011 DOI: 10.1093/abbs/gmw073] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
57 Wahb AMSE, El Kassas M, Khamis AK, Elhelbawy M, Elhelbawy N, Habieb MSE. Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol 2021; 13(11): 1753-1765 [PMID: 34904043 DOI: 10.4254/wjh.v13.i11.1753] [Reference Citation Analysis]
58 Ding Y, Pan Y, Liu S, Jiang F, Jiao J. Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV. Cancer Biol Ther 2017;18:414-24. [PMID: 28613134 DOI: 10.1080/15384047.2017.1323585] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
59 Tian Q, Sun H, Wang W, Li Q, Ding J, Di W. miRNA-365b promotes hepatocellular carcinoma cell migration and invasion by downregulating SGTB. Future Oncology 2019;15:2019-28. [DOI: 10.2217/fon-2018-0676] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
60 Lima JF, Cerqueira L, Figueiredo C, Oliveira C, Azevedo NF. Anti-miRNA oligonucleotides: A comprehensive guide for design. RNA Biol 2018;15:338-52. [PMID: 29570036 DOI: 10.1080/15476286.2018.1445959] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 13.8] [Reference Citation Analysis]
61 Lee NH, Kim SJ, Hyun J. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer. Biomedicines 2021;9:347. [PMID: 33808155 DOI: 10.3390/biomedicines9040347] [Reference Citation Analysis]
62 Montalbano R, Honrath B, Wissniowski TT, Elxnat M, Roth S, Ocker M, Quint K, Churin Y, Roederfeld M, Schroeder D, Glebe D, Roeb E, Di Fazio P. Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells. Oncotarget. 2016;7:20312-20323. [PMID: 26967385 DOI: 10.18632/oncotarget.7950] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
63 Li DY, Chen WJ, Shang J, Chen G, Li SK. Regulatory interactions between long noncoding RNA LINC00968 and miR-9-3p in non-small cell lung cancer: A bioinformatic analysis based on miRNA microarray, GEO and TCGA. Oncol Lett 2018;15:9487-97. [PMID: 29805671 DOI: 10.3892/ol.2018.8476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
64 Liu C, Wu Y, Ma J. Interaction of non-coding RNAs and Hippo signaling: Implications for tumorigenesis. Cancer Lett. 2020;493:207-216. [PMID: 32822816 DOI: 10.1016/j.canlet.2020.08.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
65 Cai H, Yang X, Gao Y, Xu Z, Yu B, Xu T, Li X, Xu W, Wang X, Hua L. Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer. Mol Ther Nucleic Acids 2019;18:787-800. [PMID: 31734559 DOI: 10.1016/j.omtn.2019.09.023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
66 Zhang S, Wang J, Wang H, Fan L, Fan B, Zeng B, Tao J, Li X, Che L, Cigliano A, Ribback S, Dombrowski F, Chen B, Cong W, Wei L, Calvisi DF, Chen X. Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans. Am J Pathol 2018;188:995-1006. [PMID: 29378174 DOI: 10.1016/j.ajpath.2017.12.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
67 Lei L, Wu J, Gu D, Liu H, Wang S. CIZ1 interacts with YAP and activates its transcriptional activity in hepatocellular carcinoma cells. Tumour Biol 2016;37:11073-9. [PMID: 26906552 DOI: 10.1007/s13277-016-4866-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
68 Tian S, Liu Y, Dong F, Dou Y, Li W, Wang J. Knockdown of microRNA-584 promotes dental pulp stem cells proliferation by targeting TAZ. Cell Cycle 2020;19:1048-58. [PMID: 32208890 DOI: 10.1080/15384101.2020.1744976] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]